JPH0125722B2 - - Google Patents

Info

Publication number
JPH0125722B2
JPH0125722B2 JP56025058A JP2505881A JPH0125722B2 JP H0125722 B2 JPH0125722 B2 JP H0125722B2 JP 56025058 A JP56025058 A JP 56025058A JP 2505881 A JP2505881 A JP 2505881A JP H0125722 B2 JPH0125722 B2 JP H0125722B2
Authority
JP
Japan
Prior art keywords
group
benzimidazole
anthelmintic
antibiotics
salicylamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56025058A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57139012A (en
Inventor
Kunitoshi Kitano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12155318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0125722(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP56025058A priority Critical patent/JPS57139012A/ja
Priority to DE2002199008 priority patent/DE10299008I2/de
Priority to GB8204765A priority patent/GB2093695B/en
Priority to DE8282300829T priority patent/DE3260921D1/de
Priority to EP82300829A priority patent/EP0059074B1/en
Priority to IE369/82A priority patent/IE52364B1/en
Priority to US06/350,641 priority patent/US4468390A/en
Priority to ZA821135A priority patent/ZA821135B/xx
Priority to AU80711/82A priority patent/AU552403B2/en
Priority to NZ199817A priority patent/NZ199817A/en
Publication of JPS57139012A publication Critical patent/JPS57139012A/ja
Publication of JPH0125722B2 publication Critical patent/JPH0125722B2/ja
Priority to NL300082C priority patent/NL300082I1/nl
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56025058A 1981-02-23 1981-02-23 Anthelmintic composition Granted JPS57139012A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP56025058A JPS57139012A (en) 1981-02-23 1981-02-23 Anthelmintic composition
DE2002199008 DE10299008I2 (de) 1981-02-23 1982-02-18 Anthelmintische Zusammensetzung un ihre Verwendung.
GB8204765A GB2093695B (en) 1981-02-23 1982-02-18 Anthelmintic composition containing macrolide antibiotics
DE8282300829T DE3260921D1 (en) 1981-02-23 1982-02-18 Anthelmintic composition and the use thereof
EP82300829A EP0059074B1 (en) 1981-02-23 1982-02-18 Anthelmintic composition and the use thereof
ZA821135A ZA821135B (en) 1981-02-23 1982-02-22 Anthelmintic composition and the use thereof
US06/350,641 US4468390A (en) 1981-02-23 1982-02-22 Anthelmintic composition and the use thereof
IE369/82A IE52364B1 (en) 1981-02-23 1982-02-22 Anthelmintic composition and the use thereof
AU80711/82A AU552403B2 (en) 1981-02-23 1982-02-23 Anthelmintic composition and use
NZ199817A NZ199817A (en) 1981-02-23 1982-02-23 Anthelmintic composition consisting of two components
NL300082C NL300082I1 (nl) 1981-02-23 2002-02-13 Anthelmintische samenstelling en het gebruik daarvan.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56025058A JPS57139012A (en) 1981-02-23 1981-02-23 Anthelmintic composition

Publications (2)

Publication Number Publication Date
JPS57139012A JPS57139012A (en) 1982-08-27
JPH0125722B2 true JPH0125722B2 (online.php) 1989-05-19

Family

ID=12155318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56025058A Granted JPS57139012A (en) 1981-02-23 1981-02-23 Anthelmintic composition

Country Status (10)

Country Link
US (1) US4468390A (online.php)
EP (1) EP0059074B1 (online.php)
JP (1) JPS57139012A (online.php)
AU (1) AU552403B2 (online.php)
DE (2) DE3260921D1 (online.php)
GB (1) GB2093695B (online.php)
IE (1) IE52364B1 (online.php)
NL (1) NL300082I1 (online.php)
NZ (1) NZ199817A (online.php)
ZA (1) ZA821135B (online.php)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426333B1 (en) * 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
FR2753377B1 (fr) * 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
MA19678A1 (fr) * 1982-01-13 1983-10-01 Ciba Geigy Ag Agents anti-helmintiques.
DE3410348A1 (de) * 1984-03-21 1985-10-03 Helmut Dr. Bozen Schwienbacher Verfahren zur bekaempfung von fischmykosen und mittel zur durchfuehrung des verfahrens
EP0354593B1 (de) * 1986-01-25 1993-03-03 Hoechst Aktiengesellschaft Schädlingsbekämpfungsmittel
GB9024924D0 (en) * 1990-11-16 1991-01-02 Beecham Group Plc Novel compositions
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
AU2003236405B2 (en) * 1999-04-14 2007-10-25 Merial Ltd Anthelmintic Composition
AU691990B2 (en) * 1994-11-28 1998-05-28 Virbac S.A. Equine anthelmintic formulations
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
FR2739778B1 (fr) * 1995-10-13 1997-12-12 Virbac Lab Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
WO1997046204A2 (en) 1996-06-05 1997-12-11 Ashmont Holdings Limited Injectable compositions
DE19654079A1 (de) 1996-12-23 1998-06-25 Bayer Ag Endo-ekto-parasitizide Mittel
ES2359973T3 (es) * 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US20040077703A1 (en) * 2002-10-02 2004-04-22 Soll Mark D. Nodulisporic acid derivative spot-on formulations for combating parasites
CA2521268C (en) * 2003-04-04 2012-10-16 Merial Ltd. Topical anthelmintic veterinary formulations
US7049076B2 (en) * 2003-07-09 2006-05-23 Sentigen Biosciences, Inc. Method for assaying protein—protein interaction
US7396819B2 (en) 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US7671034B2 (en) * 2003-12-19 2010-03-02 Merial Limited Stabilized formulation of ivermectin feed premix with an extended shelf life
WO2005094210A2 (en) 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
EP1734954A4 (en) * 2004-04-07 2007-05-30 Intervet Int Bv EFFECTIVE COMPOSITION OF A BENZIMIDAZOLE, AVERMECTIN AND PRAZIQUANTEL AND RELEVANT APPLICATION METHOD
GB0508993D0 (en) 2005-05-03 2005-06-08 Syngenta Participations Ag Pesticidal compositions
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
MX2008016411A (es) 2006-07-05 2009-04-28 Aventis Agriculture Compuestos derivados de 1-aril-5-alquil pirazol, procesos para hacerlos y metodos para usarlos.
US7919522B2 (en) * 2007-05-03 2011-04-05 Merial Limited Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds
PL3088384T3 (pl) 2007-05-15 2019-06-28 Merial, Inc. Związki aryloazol-2-ilo-cyjanoetyloaminowe, sposób ich wytwarzania oraz sposób ich stosowania
WO2009070687A1 (en) 2007-11-26 2009-06-04 Merial Limited Solvent systems for pour-on formulations for combating parasites
PT2331068T (pt) 2008-10-08 2017-03-13 Zoetis Services Llc Composições anti-helmínticas de benzimidazol
PL3050874T3 (pl) 2008-11-14 2019-07-31 Merial Inc. Wzbogacone enancjomerycznie aryloazol-2-ilocyjanoetyloaminowe związki pasożytobójcze
SG171751A1 (en) 2008-11-19 2011-07-28 Merial Ltd Compositions comprising an aryl pyrazole and/ or a formamidine methods and uses thereof
BRPI1009199A2 (pt) 2009-03-17 2016-03-08 Concert Pharmaceuticals Inc compostos de pirazinoisoquinolina
WO2011069143A1 (en) 2009-12-04 2011-06-09 Merial Limited Pesticidal bis-organosulfur compounds
ME02432B (me) 2009-12-17 2016-09-20 Merial Inc Antiparazitska jedinjenja dihidroazola i kompozicije koje ih sadrže
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
DK2640728T3 (en) 2010-11-16 2016-11-28 Merial Inc NEW MONENSINDERIVATER FOR TREATMENT AND PREVENTION OF protozoal INFECTIONS
US8946270B2 (en) 2011-06-27 2015-02-03 Merial Limited Amido-pyridyl ether compounds and compositions and their use against parasites
WO2013003168A1 (en) 2011-06-27 2013-01-03 Merial Limited Novel insect-repellent coumarin derivatives, syntheses, and methods of use
PT3172964T (pt) 2011-09-12 2020-11-30 Boehringer Ingelheim Animal Health Usa Inc Composições parasiticidas compreendendo um agente ativo de isoxazolina, método e utilizações das mesmas
WO2013044118A2 (en) 2011-09-23 2013-03-28 Merial Limited Indirect modeling of new repellent molecules active against insects, acarids, and other arthropods
JP6249568B2 (ja) 2011-11-17 2017-12-20 メリアル インコーポレイテッド アリールピラゾールと置換イミダゾールを含む組成物、その使用方法
CN104168900A (zh) 2012-02-06 2014-11-26 梅里亚有限公司 包含全身性地起作用的活性剂的杀寄生虫口服兽用组合物、方法及其用途
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
NZ711847A (en) 2012-04-20 2015-11-27 Merial Inc Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
CA2891926A1 (en) 2012-11-20 2014-05-30 Merial, Inc. Anthelmintic compounds and compositions and method of using thereof
LT2950795T (lt) 2013-01-31 2018-06-25 Merial, Inc. Leišmaniozės gydymo ir naikinimo būdas naudojant feksinidazolą
CN105873925B (zh) 2013-11-01 2019-09-10 勃林格殷格翰动物保健美国公司 抗寄生物的和杀虫的异噁唑啉化合物
ES2765405T3 (es) 2014-04-17 2020-06-09 Boehringer Ingelheim Animal Health Usa Inc Utilización de compuestos de malononitrilo para proteger animales de parásitos
MX375153B (es) 2014-05-19 2025-03-06 Boehringer Ingelheim Animal Health Usa Inc Compuestos antihelminticos.
BR122020023385B1 (pt) 2014-06-19 2021-05-25 Merial, Inc composições parasiticidas compreendendo derivados de indol, métodos e usos dos mesmos
US10864193B2 (en) 2014-10-31 2020-12-15 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising fipronil at high concentrations
PY1609250A (es) 2015-02-26 2018-03-01 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
EP3280413A1 (en) 2015-04-08 2018-02-14 Merial, Inc. Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
US20160347829A1 (en) 2015-05-27 2016-12-01 Merial Inc. Compositions containing antimicrobial IgY antibodies, for treatment and prevention of disorders and diseases caused by oral health compromising (OHC) microorganisms
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
CN110381738B (zh) 2016-10-14 2021-07-16 勃林格殷格翰动物保健美国公司 农药的和杀寄生物的乙烯基异噁唑啉化合物
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
EP3644741B1 (en) 2017-06-26 2023-06-07 Boehringer Ingelheim Animal Health USA Inc. Dual active parasiticidal granule compositions, methods and uses thereof
ES2944616T3 (es) 2017-08-14 2023-06-22 Boehringer Ingelheim Animal Health Usa Inc Compuestos de pirazol-isoxazolina plaguicidas y parasiticidas
EP3749096A1 (en) 2018-02-08 2020-12-16 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
MX2021000293A (es) 2018-07-09 2021-07-15 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos antihelminticos.
EP3883648A1 (en) 2018-11-20 2021-09-29 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
AU2020208145B2 (en) 2019-01-16 2023-02-02 Boehringer Ingelheim Vetmedica Gmbh Topical compositions comprising a neonicotinoid and a macrocyclic lactone, methods and uses thereof
PY2013845A (es) 2019-03-01 2021-02-09 Boehringer Ingelheim Animal Health Usa Inc Composiciones inyectables de clorsulón, sus métodos y usos
JP7637630B2 (ja) 2019-03-19 2025-02-28 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 駆虫性アザベンゾチオフェンおよびアザベンゾフラン化合物
CA3146043A1 (en) 2019-07-22 2021-01-28 Intervet International B.V. Soft chewable veterinary dosage form
PH12022553222A1 (en) 2020-05-29 2024-02-12 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic heterocyclic compounds
JP2024504208A (ja) 2020-12-21 2024-01-30 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー イソオキサゾリン化合物を含む殺寄生虫首輪
WO2025257633A1 (en) 2024-06-12 2025-12-18 Boehringer Ingelheim Vetmedica Gmbh Long-acting castor oil-containing injectable formulations and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (online.php) * 1972-06-08 1974-02-08
PH15982A (en) * 1977-10-03 1983-05-18 Merck & Co Inc Selective hydrogenation producta of c-076 compounds and derivatives thereof
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4203976A (en) * 1978-08-02 1980-05-20 Merck & Co., Inc. Sugar derivatives of C-076 compounds
US4289760A (en) * 1980-05-02 1981-09-15 Merck & Co., Inc. 23-Keto derivatives of C-076 compounds

Also Published As

Publication number Publication date
JPS57139012A (en) 1982-08-27
US4468390A (en) 1984-08-28
DE10299008I2 (de) 2004-10-21
ZA821135B (en) 1983-02-23
DE10299008I1 (de) 2002-07-04
IE52364B1 (en) 1987-09-30
DE3260921D1 (en) 1984-11-15
AU552403B2 (en) 1986-05-29
EP0059074B1 (en) 1984-10-10
GB2093695A (en) 1982-09-08
EP0059074A1 (en) 1982-09-01
NL300082I1 (nl) 2002-04-02
NZ199817A (en) 1984-12-14
AU8071182A (en) 1982-09-02
IE820369L (en) 1982-08-23
GB2093695B (en) 1984-03-28

Similar Documents

Publication Publication Date Title
Finlay et al. Viomycin, a new antibiotic active against mycobacteria
CN108699052B (zh) 驱虫缩酚酸肽化合物
Rood et al. Isolation and characterization of multiply antibiotic-resistant Clostridium perfringens strains from porcine feces
Girard et al. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution
CN107835818B (zh) 驱虫缩酚酸肽化合物
DE69633734T2 (de) Antibakterielle nitroimidazolverbindungen und verfahren zu deren verwendung
DE68920673T2 (de) 13-Substituierte Milbemycinderivate, ihre Herstellung und Verwendung.
AU2009308180B2 (en) Methods for treating gastrointestinal diseases
RS54904B1 (sr) Antibakterijske farmaceutske kompozicije
Hirano et al. Structure–activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents
NZ199817A (en) Anthelmintic composition consisting of two components
Sanfilippo et al. Biological activity of a new class of rifamycins Spiro-piperidyl-rifamycins
JPS63119486A (ja) Ｌｌ−ｆ２８２４９化合物の２３−オキソ（ケト）および２３−イミノ誘導体
DE69309665T2 (de) Antiparasitäre avermectin und milbemycin derivate
WO2005007143A2 (en) Use of makrolides and ketolides for the treatment of tuberculosis
US4672056A (en) Erythromycin A derivatives and method of use
JP2837957B2 (ja) 駆虫薬
DE60025370T2 (de) 9a-azalide mit antibakterieller wirkung
EP1134216B1 (en) Anti-drug resistant strain agents and antichlamydia agents
DE60133273T2 (de) Inhibitoren von peptid deformylase
US4794105A (en) Method for treatment of swine dysentery
JPH072672A (ja) 抗菌性配合製剤
DE60112280T2 (de) Inhibitoren von peptid-deformylase
Muri et al. Anti-Helicobacter pylori agents. An update
Woodruff et al. The antibiotics explosion